Growth vs. Value
If there is one truth that investors recognize, is that there is a new sheriff in town, ever since the middle of 2010 growth stock massively outperformed value stocks. This…
If there is one truth that investors recognize, is that there is a new sheriff in town, ever since the middle of 2010 growth stock massively outperformed value stocks. This…
If you believe politicians are on your side, you might conclude that the governments worldwide do not know what to do about the SAR-CoV-2 challenge. This article is for paid…
We do not understand why. Let's take that back. We do understand why. Apple pulled guidance for future financial performance. But given the excellent performance this last quarter and the…
One of the sectors that have gone unnoticed is the automobile sector. Unless you are in the business, you would not know that manufacturers and auto dealers are doing very…
The large-cap technology stocks in the US markets have been the place to be for some time now. Secondarily, the best place to be has been large-cap US stocks in…
Bitcoin has been in a bearish consolidation pattern ever since the price hit its $20,000 peak in January of 2018. The bulls have tried to stay hopeful, which is very…
Every now and again, we like to discuss off the run names in the investment landscape. One of those names is Synchrony Financial. This article is for paid members -…
Shopping from home is the name of the game. Take a walk around your neighborhood, and you will see, and Amazon, FedEx, and UPS delivery trucks out doing their thing.…
Several companies are competing to find a vaccine to combat the SARS-CoV-2 virus. We have talked about a few of the candidates, but not our 2nd favorite play. AstraZeneca. This…
In mid-September, we suggested that investors take a closer look at Pfizer, the big ($211 billion market cap) pharmaceutical company. This article is for paid members - please login or…